Recent USPTO Activity May Signal Shift in Treatment of Pharmaceutical Patents in AIA Proceedings

The America Invents Act provides for adversarial proceedings for challenging patents in the United States Patent and Trademark Office — including inter partes review and post grant review — which are faster, cheaper, and have a lower burden of proof than litigation in federal court.

Read More: Recent USPTO Activity May Signal Shift in Treatment of Pharmaceutical Patents in AIA Proceedings


Download PDF Share Back To Listing
Loading data